Condensed Declaration

Writer of original, whole declaration: James T. Kimball Past President Discovery Experimental And Developmental, Inc., Past President ASTAK, Inc., Past President Global Health Information & Medical Research Institute, Inc., Past President B&B Freight Forwarding, Inc., Past President Discovery Tour Wholesalers, Inc., Past President American Transportation, Inc.

James Kimball has passed away. His past wife, Jo Kimball, can be contacted by:

phone- (813) 973-0996
fax- (813) 973-7002
e-mail- prodedi@discovery-experimental.com
writing-
James Kimball no longer can be written to. To get in contact with his family, you may use the specified e-mail address above.

Condensed Declaration of James T. Kimball

The statements contained herein are true and correct to the best of James T. Kimball's (“KIMBALL”) knowledge and belief. I refer to myself in the third person to advance the readability of my statement. Under the penalty of perjury and willing to take a professionally administered polygraph exam and/or truth serum as to all statements contained herein; KIMBALL, declares as follows:

1. Around 1990 KIMBALL formed Discovery Experimental and Development, Inc. (“DEDI”), a pharmaceutical research company to research and develop products to better the health of the general public. KIMBALL additionally formed ASTAK, Inc., a dietary supplement research company, plus formed a non-profit organization, Global Health Information and Medical Research Institute, Inc. (“GHI/MRI”), in an effort to supply to the public truthful information regarding any medical affliction, free of charge.

2. These corporations existed from 1990 to 2000. Over the years, KIMBALL was the president of the above companies and, as such, did not receive any salary or corporate issued bonuses. The majority of people, companies and universities that assisted DEDI and GHI/MRI did so to help develop products to help the ailing, also received no payment for their services. The entities which became involved in this effort were doctors, scientists, universities and private corporations from around the world.

3. Over that ten-year span, all companies with which KIMBALL was affiliated with generated approximately three million dollars in revenue which amounts to $300,000 average per year. Three hundred thousand dollars per year might pay the salaries of two or three top scientists in the research field, yet KIMBALL’s affiliated companies operating within this budget paid employee salaries, and maintained a 6,000 square foot research facility in Wesley Chapel, Florida; a 2,000 square foot facility in Tijuana, Mexico; and small offices in San Diego, California and Tampa, Florida. On site scientists at Wesley Chapel consisted of two over the years, while off site doctors and scientists assisting KIMBALL were at: Temple University; University of Southern California; University of South Florida; Florida State University; University of Toronto; the National Institute of Health; and a multitude of private research companies world-wide. The vast majority of scientists, doctors and such assisted KIMBALL’s companies in an effort to develop products did so from their hearts, receiving no remuneration at all for their services.

4. The first active ingredient DEDI developed was liquid selegiline (LS) which, at its origin, is natural and extracted from a plant. Classified by scientists as a botanical, this product alone had the potential to improve everyone's quality of life—everyone’s. Even though it addressed terminal diseases, LS enhanced the immune system and extended life dramatically. Over the years selegiline proved to do that and much more. Prior to 1991 no one else in the world had been able to produce LS in a pure form and stabilize it, nor to the present date, to KIMBALL’s knowledge.

5. The attributes of properly made pure selegiline are well known by scientists, and very simple. Once in the blood stream, the product stimulates a tissue in the brain to produce another chemical naturally, which depletes as we age. In some people this brain tissue degenerates too quickly and people are afflicted with terminal neurological diseases such as Parkinson’s. This tissue is called the substantia nigra, which emits a chemical that retards the degeneration of brain cells and revives dying neurons, as test results have proven. Without any substantia nigra at all to emit the chemical to sustain brain cell life, the life expectancy of human beings is estimated to be under 5 years. As people age, our substantia nigra degenerates, the immune system drops, hormone levels drop, as do all other bodily functions, such as mobility and sex drive, due to the fact the brain cells are malfunctioning and dying from the increasing shortage of this chemical. The brain runs the body. If the brain is operating properly, the body normally functions properly.

6. Over a ten-year period, DEDI’s selegiline product, hard as it may be to believe, proved to be effective in treating Parkinson’s disease, Alzheimer’s disease, Multiple Sclerosis, nervous system disorders, pain, hormone depletion, high blood pressure, cancer and others. People using DEDI’s selegiline for general health, or quality of life, who had no medical problems also reported dramatic improvements in their quality of life, including increased memory, less required sleep, increased energy levels, increased sex drive, increased mobility and cognitive functions. Older people were driving again and getting out of wheel chairs. Over the years, tests focusing on life extension in animals revealed around a 50% increase. No serious side effects were reported in ten-years of public use with DEDI’s product. Of course, no good deed goes unpunished, which DEDI’s and KIMBALL’s experience certainly confirms.

7. KIMBALL learned early on about major problems within the pharmaceutical industry and the FDA. KIMBALL also learned from top scientists and doctors around the world that, almost without exception, every active chemical ingredient within every dietary supplement and pharmaceutical drug differs by manufacturer. Sometimes the differences are dramatic, even though the chemical name of their active ingredient is allowed to be called the same. That is why some generic drugs work better than others and some cause adverse side effects. However, some generic drugs are made better and purer with less adverse side effects than the original drugs introduced, the same with dietary supplements with allegedly the same active ingredients. The differences with dietary supplements derived from food, plants or a synthesized version is the side effects are normally negligible to none, where drugs synthesized by other means often produce serious side effects, up to death. DEDI found producing an effective active ingredient requires exacting high purity standards. Those standards are not the standards of the FDA or the pharmaceutical industry. Their standards are all driven by the profit motive.

8. FDA employees have been caught on more than one occasion receiving graft from pharmaceutical companies. Drug companies find it cheaper to produce an impure active ingredient than a pure one. Trials and test results on new drugs going through the FDA approval process are also too often altered. DEDI found working with top scientists and researchers around the world that most of the products have been discovered that will treat or cure most all terminal diseases and afflictions, including dramatic life extension. However, that information is suppressed by the pharmaceuticals industry, the FDA and even some government officials

9. The pharmaceutical industry blocks the information and development of these products because many of them are much cheaper and far more effective with less side effects than the products they now have in the marketplace. If these new, much more effective, products were allowed to get to the consumer, even one could eliminate the sale of 50 to 100 over-the-counter (“OTC”) and prescription (“RX”) drugs. That could easily cost the pharmaceutical companies, which are currently producing those products, hundreds of billions of dollars a year in income. It should come as no surprise then that the pharmaceutical industry effectively controls the FDA.

10. Somerset Pharmaceuticals Inc. sells a product, Eldepryl, similar to, but substantially less pure, than LS. KIMBALL naively spoke several times to Dana Barnett, Somerset’s President and Vice-President of parent company Mylan Laboratories, Inc., about the issue of humanity, human rights, and everyone’s right to a healthy life. Around 1995, KIMBALL futilely met with Barnett in an attempt to persuade Somerset and its colleagues to back off from their attempts to put DEDI out of business, as described below.

11. Somerset and Watson Pharmaceuticals, with affiliates such as Sandoz Pharmaceuticals, instigated the FDA and the State of Florida Dept. of Health (“DOH”) to target and destroy DEDI and Kimball over a period of 10 years, which ended up with DEDI out of business and KIMBALL sent to prison for 13 years. But, KIMBALL is not the only casualty here. Their combined actions cost the lives and the quality of life of hundreds of thousands of Americans, if not millions. The people involved in this lethal action include, but are by no means limited to: Don Leggett, Dennis Degan, Agent Randy Matteson, Agent Chastony, Dr. Katz, Attorney Jennifer Bragg-Jones, all with the FDA; Jerry Hill, Agent Gregory Jones, Agent Deborah Orr and Attorney Robert Daniti, all with the DOH; Assistant U.S. Attorney Michael Rubinstein; Sean McWeeney; ex-FBI agent; and Bradley Vaughn, Probation Officer. These names are not idly listed. As will be explained below, each of these individuals participated in the plot to kill off LS and destroy all involved with it. Others involved in the conspiracy are not mentioned in this declaration; however, their names are available.

12. Somerset Pharmaceuticals had acquired the rights and FDA approval for a product, selegiline hydrochloride, which contained an impure active ingredient. This selegiline hydrochloride product was manufactured by a company in Budapest, Hungary, then shipped to the United States for redistribution by Somerset Pharmaceuticals. Somerset named this drug Eldepryl. The FDA did not however approve Eldepryl to be a drug by itself. The FDA approved its use “only” to be used in combination with a dangerous prescription drug with serious side effects called Levodopa, and only for use to treat “one single disease”: Parkinson’s. KIMBALL’s companies were attempting to, and ultimately did, develop a different chemical entity that was similar, but much purer than Somerset’s, to be used by itself as a dietary supplement.

13. Heading up the trials for Somerset was a man named Ira Shoulson. Dr. Shoulson oversaw the trials and testing of Somerset’s selegiline hydrochloride product. The testing of Somerset’s selegiline hydrochloride, which was also conducted in Budapest, under the watchful eye and control of Dr. Shoulson, was manipulated so it would not reveal an unknown contaminant which the University of Toronto found. DEDI’s head scientist believed he had identified the unknown contaminant as a neurotoxin. The FDA and the DOH were both advised about the contaminants in Eldepryl but failed to respond. The government’s own records reveal the contaminants and the Somerset cover up. Still, they did nothing, letting the compromised public who were dying of incurable Parkinson’s disease further suffer and die sooner with the use of Somerset’s product.

14. While KIMBALL’s companies were researching the methods to properly make selegiline, prior to its development in the spring of 1991, Somerset, the FDA and DOH formed their compact. They earmarked DEDI’s premises and committed numerous illegalities which led to KIMBALL’s arrest in 1991. However, that case was thrown out due to their combined illegal acts.

15. In 1991, as soon as selegiline was developed, KIMBALL petitioned the FDA for an administrative determination that DEDI’s selegiline product be classified as a food additive, vitamin class of product, i.e., dietary supplement, with medical claims. The FDA then violated KIMBALL’s First Amendment right to petition, his Fifth Amendment right to due process, as well as the laws which govern it, returning KIMBALL’s petition without administrative review.

16. Shortly after its development of selegiline, Somerset moved its headquarters from New Jersey to Tampa, Florida, 15 miles from DEDI, remaining there until KIMBALL was indicted and convicted in 2000. After Somerset moved to Tampa, it hired private detectives to work with the DOH and federal agents in surveillancing DEDI and KIMBALL’s activities. The DOH and the federal agents shared information with Somerset, an illegal act in itself. The government conspirators even told Somerset not to file a civil suit against DEDI and KIMBALL until after the government and DOH conducted their planned search, seizure and confiscations of DEDI, and KIMBALL’s residence, set for May 12, 1993. The remarkable records and written communications between the U.S. Government employees and the representatives of Somerset Pharmaceuticals, and their attorneys, are on this website, viewable on The Conspiracy Page.

17. KIMBALL had surmised that Mylan Laboratories, a large drug producer, affiliated with Sandoz, had told their branded pharmaceutical company, Somerset, to move to Tampa to assist, influence and corrupt any and all officials they could, to get rid of DEDI and KIMBALL. Was this paranoia? No, KIMBALL had real enemies who were out to get rid of him.

18. Prior to the raid on May 12,1993, with the help of numerous experts world-wide, DEDI had developed products exceedingly effective in treating life threatening viruses, bacterial infections and fungi infections. Additionally, DEDI had a product in process, an extract from a mushroom, which had been proven to enhance the immune system so high it had the ability to treat and cure skin cancer. KIMBALL collaborated with Japanese scientists on the project. At the same time DEDI had acquired another extract from Europe which scientists had told KIMBALL worked effectively to treat liver cancer, which is deemed deadly and untreatable in the United States. However, the DOH conspirators illegally confiscated those research products on May 12, 1993 and never returned them.

19. With the help of a renowned scientist from the National Institute of Health (“NIH”), Dr. Willie Burgdorfer, and the use of the NIH’s sophisticated equipment, a unique form of a mineral was developed by DEDI. When later perfected, this specifically engineered mineral was encircled by a protein which proved to be lethal against all viruses, bacteria and fungi tested against it, including full blown AIDS. Without the direct assistance of Dr. Willie Burgdorfer from the Rocky Mountain Division of the NIH, the specific engineered mineral would never have been developed to its highest potency. But, the original version of this mineral product, along with the perfected version under the NIH, has never been produced by anyone to date. Over the years with all the testing and human trials conducted, this single product, and versions of it produced by DEDI, revealed staggering results.

20. The testing, trials and human use of varying potencies of DEDI’s mineral product had not only revealed its lethal powers by killing the AIDS virus, it additionally inhibited or killed the spirochetes in Lyme disease, viruses and bacteria attributed to Hepatitis C, along with staph infections. It was also effective in treating flesh-eating staph. It was reported by one doctor using the product in patients at the final stages of leukemia that it normalized the white/red blood cells. Leukemia symptoms disappeared, meaning the leukemia wasn’t a cancer at all; it was caused by some unknown virus.